1 | 12 MG/KG GSK2402968 | - | - | - | - | 1件: 113 113 💬
|
2 | 2'-O-(2-methoxyethyl) phosphorothioate antisense oligonucleotide targeting CD49D RNA | - | - | - | - | 1件: 113 113 💬
|
3 | 2011-2012 seasonal FLU vaccine intramuscular | - | - | - | - | 2件: 3 3, 113 💬
|
4 | 2011-2012 seasonal FLU vaccine subcutaneous | - | - | - | - | 2件: 3 3, 113 💬
|
5 | 29180.00.00, 34681.00.00, 34681.01.00, 34681.02.00 | - | - | - | - | 1件: 113 113 💬
|
6 | 3 MG/KG GSK2402968 | - | - | - | - | 1件: 113 113 💬
|
7 | 30 seconds SIT TO stand test | - | - | - | - | 1件: 113 113 💬
|
8 | 4-benzyl-2-naphthalen-1-YL-1,2,4- thiadiazolidine-3,5-dione | - | - | - | - | 1件: 113 113 💬
|
9 | 4-benzyl-2-naphthalen-1-YL-1,2,4-thiadiazolidine-3,5-dione | - | - | - | - | 1件: 113 113 💬
|
10 | 5-(ethylsulfonyl)-2-(naphthalen-2-YL)benzo[D]oxazole | - | - | - | - | 1件: 113 113 💬
|
11 | 6 MG/KG GSK2402968 | - | - | - | - | 1件: 113 113 💬
|
12 | 9 MG/KG GSK2402968 | - | - | - | - | 1件: 113 113 💬
|
13 | AAV1-gamma-sarcoglycan vector injection | - | - | - | - | 1件: 113 113 💬
|
14 | AB-1003 dose level 1 | - | - | - | - | 1件: 113 113 💬
|
15 | AB-1003 dose level 2 | - | - | - | - | 1件: 113 113 💬
|
16 | ACE-031 0.5 MG/KG Q4WK | - | - | - | - | 1件: 113 113 💬
|
17 | ACE-031 1.0 MG/KG Q2WK | - | - | - | - | 1件: 113 113 💬
|
18 | ACE-083 | - | - | - | - | 2件: 10 10, 113 💬
|
19 | Activity monitor | - | - | - | - | 1件: 113 113 💬
|
20 | Actonel once A week 5MG film coated tablets | 1件: Risedronic acid Risedronic acid | 3件: Risedronate sodium
Risedronate sodium
,
Risedronic acid
,
Risedronate sodium monohydrate
💬
| 1件: FDPS FDPS 💬
| 3件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬 | 1件: 113 113 💬
|
21 | Adeno-associated viral vector serotype 8 containing THE human MD1 gene | - | - | - | - | 1件: 113 113 💬
|
22 | Adeno-associated viral vector serotype 9 containing THE human MINI-dystrophin gene | - | - | - | - | 1件: 113 113 💬
|
23 | Adeno-associated virus serotype 9 carrying THE human fukutin-related protein and target sequence OF THE MIR-208A | - | - | - | - | 1件: 113 113 💬
|
24 | Adeno-associated virus serotype RH74 containing THE human delandistrogene moxeparvovec dystrophin gene | 1件: Delandistrogene moxeparvovec Delandistrogene moxeparvovec | 1件: Delandistrogene moxeparvovec
Delandistrogene moxeparvovec
💬
| 1件: DMD DMD 💬
| 5件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬 | 1件: 113 113 💬
|
25 | Adeno-associated virus serotype RH74 containing THE human micro- dystrophin gene | - | - | - | - | 1件: 113 113 💬
|
26 | Adeno-associated virus serotype RH74 containing THE human micro-dystrophin gene | - | - | - | - | 1件: 113 113 💬
|
27 | Agamree | 1件: Vamorolone Vamorolone | 1件: Vamorolone
Vamorolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 113 113 💬
|
28 | Albuterol | 1件: Albuterol Albuterol | 2件: Albuterol sulfate
Albuterol sulfate
,
Albuterol
💬
| 1件: ADRB2 ADRB2 💬
| 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 8件: 12 12, 13, 86, 113, 231, 256, 299, 340 💬
|
29 | Allogeneic cardiosphere-derived cells | 1件: Allogeneic Cardiosphere-Derived Cells Allogeneic Cardiosphere-Derived Cells | - | - | - | 1件: 113 113 💬
|
30 | Amino acid intake | - | - | - | - | 1件: 113 113 💬
|
31 | Amondys 45 | - | - | - | - | 1件: 113 113 💬
|
32 | ANTI-myostati | - | - | - | - | 1件: 113 113 💬
|
33 | ANTI-myostatin adnectin | - | - | - | - | 1件: 113 113 💬
|
34 | AOC 1001 | 1件: AOC 1001 AOC 1001 | - | - | - | 1件: 113 113 💬
|
35 | AOC 1020 | - | - | - | - | 1件: 113 113 💬
|
36 | AOC 1044 | - | - | - | - | 1件: 113 113 💬
|
37 | ARO-DM1 FOR injection | - | - | - | - | 1件: 113 113 💬
|
38 | ARO-DUX4 FOR injection | - | - | - | - | 1件: 113 113 💬
|
39 | Aspirin | 1件: Acetylsalicylic acid Acetylsalicylic acid | 1件: Aspirin
Aspirin
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 12件: 13 13, 22, 34, 46, 49, 51, 86, 113, 158, 210, 231, 271 💬
|
40 | ATA-200 | - | - | - | - | 1件: 113 113 💬
|
41 | Ataluren | 1件: Ataluren Ataluren | 1件: Ataluren
Ataluren
💬
| - | - | 6件: 19 19, 113, 140, 246, 299, 329 💬
|
42 | Ataluren 1000 MG | 1件: Ataluren Ataluren | 1件: Ataluren
Ataluren
💬
| - | - | 1件: 113 113 💬
|
43 | Ataluren 125 MG | 1件: Ataluren Ataluren | 1件: Ataluren
Ataluren
💬
| - | - | 1件: 113 113 💬
|
44 | Ataluren 250 MG | 1件: Ataluren Ataluren | 1件: Ataluren
Ataluren
💬
| - | - | 1件: 113 113 💬
|
45 | ATL 1102 | - | - | - | - | 1件: 113 113 💬
|
46 | ATL1102 | 1件: ATL1102 ATL1102 | - | - | - | 2件: 13 13, 113 💬
|
47 | ATL1102 25MG | 1件: ATL1102 ATL1102 | - | - | - | 1件: 113 113 💬
|
48 | ATL1102 50MG | 1件: ATL1102 ATL1102 | - | - | - | 1件: 113 113 💬
|
49 | ATX-01 | 1件: ATX-01 ATX-01 | - | - | - | 1件: 113 113 💬
|
50 | ATYR1940 | 1件: ATYR-1940 ATYR-1940 | - | - | - | 1件: 113 113 💬
|
51 | Autologous bone marrow mononuclear cell transplantation | - | - | - | - | 1件: 113 113 💬
|
52 | AVI-4658 | - | - | - | - | 1件: 113 113 💬
|
53 | AVI-4658 FOR injection | - | - | - | - | 1件: 113 113 💬
|
54 | BB-301: dose escalation phase 1B cohort 1 | 1件: BB-301 BB-301 | - | - | - | 1件: 113 113 💬
|
55 | BB-301: dose escalation phase 1B cohort 2 | 1件: BB-301 BB-301 | - | - | - | 1件: 113 113 💬
|
56 | BB-301: dose escalation phase 1B cohort 3 | 1件: BB-301 BB-301 | - | - | - | 1件: 113 113 💬
|
57 | BB-301: dose expansion phase 2A | 1件: BB-301 BB-301 | - | - | - | 1件: 113 113 💬
|
58 | BBM-D101 | - | - | - | - | 1件: 113 113 💬
|
59 | BBP-418 | - | - | - | - | 1件: 113 113 💬
|
60 | Beck depression inventory | - | - | - | - | 1件: 113 113 💬
|
61 | Beetroot juice extract | - | - | - | - | 1件: 113 113 💬
|
62 | Berg balance scale | - | - | - | - | 4件: 6 6, 13, 113, 149 💬
|
63 | Betaloc ZOK 100, 95 MG | - | - | - | - | 1件: 113 113 💬
|
64 | Betaloc ZOK 25, 23,75 MG | - | - | - | - | 1件: 113 113 💬
|
65 | BIO101 | - | - | - | - | 1件: 113 113 💬
|
66 | Biological: umbilical cord based allogenic mesenchymal stem cell | - | - | - | - | 1件: 113 113 💬
|
67 | Bisoprolol | 1件: Bisoprolol Bisoprolol | 2件: Bisoprolol fumarate
Bisoprolol fumarate
,
Bisoprolol
💬
| 1件: ADRB1 ADRB1 💬
| 13件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 4件: 58 58, 67, 86, 113 💬
|
68 | Bisoprolol fumarate | 1件: Bisoprolol Bisoprolol | 2件: Bisoprolol fumarate
Bisoprolol fumarate
,
Bisoprolol
💬
| 1件: ADRB1 ADRB1 💬
| 13件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 113 113 💬
|
69 | Bisphosphonate treatment | - | - | - | - | 2件: 113 113, 299 💬
|
70 | Blood assays | - | - | - | - | 1件: 113 113 💬
|
71 | Blood sample | - | - | - | - | 28件: 2 2, 3, 8, 13, 34, 46, 49, 51, 53, 61, 65, 66, 67, 84, 88, 96, 97, 107, 113, 127, 195, 206, 235, 274, 280, 288, 294, 299 💬
|
72 | BLS-M22 | 1件: BLS-M22 BLS-M22 | - | - | - | 1件: 113 113 💬
|
73 | BMN 044 | 1件: BMN-044 BMN-044 | - | - | - | 1件: 113 113 💬
|
74 | BMN 044 IV 6 MG/KG | 1件: BMN-044 BMN-044 | - | - | - | 1件: 113 113 💬
|
75 | BMN 044 IV 9 MG/KG | 1件: BMN-044 BMN-044 | - | - | - | 1件: 113 113 💬
|
76 | BMN 044 SC 6 MG/KG | 1件: BMN-044 BMN-044 | - | - | - | 1件: 113 113 💬
|
77 | BMN 045 | 1件: BMN-045 BMN-045 | - | - | - | 1件: 113 113 💬
|
78 | BMN 053 | - | - | - | - | 1件: 113 113 💬
|
79 | BMN 351 | - | - | - | - | 1件: 113 113 💬
|
80 | BMN053 | 1件: BMN-053 BMN-053 | - | - | - | 1件: 113 113 💬
|
81 | BMS-986089-01 (RO7239361) , ANTI-myostatin | - | - | - | - | 1件: 113 113 💬
|
82 | BMS-986089-01 (RO7239361), ANTI-myostatin | - | - | - | - | 1件: 113 113 💬
|
83 | BMS-986089-01, ANTI-myostatin | - | - | - | - | 1件: 113 113 💬
|
84 | Bocidelpar | 1件: Bocidelpar Bocidelpar | 2件: Bocidelpar
Bocidelpar
,
Bocidelpar sulfate
💬
| 1件: NR1C3 NR1C3 💬
| 12件: AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 1件: 113 113 💬
|
85 | Botulinum toxin type A | 1件: Botulinum toxin type A Botulinum toxin type A | 2件: Botulinum toxin type A
Botulinum toxin type A
,
Prabotulinumtoxin A
💬
| 1件: SNAP25 SNAP25 💬
| 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 11件: 2 2, 5, 6, 7, 13, 15, 17, 47, 113, 149, 171 💬
|
86 | Brief pain inventory short-form | - | - | - | - | 1件: 113 113 💬
|
87 | Cabaletta | 1件: Trehalose Trehalose | - | - | - | 1件: 113 113 💬
|
88 | Calcichew D3 forte | - | - | - | - | 1件: 113 113 💬
|
89 | Calcifediol | 1件: Calcifediol Calcifediol | 1件: Calcifediol
Calcifediol
💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 113 113 💬
|
90 | Canakinumab | 1件: Canakinumab Canakinumab | 1件: Canakinumab
Canakinumab
💬
| 1件: IL1B IL1B 💬
| 43件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬 | 11件: 46 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
91 | CAP-1002 | - | - | - | - | 1件: 113 113 💬
|
92 | Cardiac MRI | - | - | - | - | 3件: 113 113, 215, 216 💬
|
93 | Cardiovascular profile | - | - | - | - | 1件: 113 113 💬
|
94 | Carvedilol | 1件: Carvedilol Carvedilol | 2件: Carvedilol
Carvedilol
,
Carvedilol phosphate
💬
| 5件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
| 15件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 6件: 6 6, 46, 57, 86, 113, 210 💬
|
95 | Casimersen | 1件: Casimersen Casimersen | 1件: Casimersen
Casimersen
💬
| 1件: DMD DMD 💬
| 5件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬 | 1件: 113 113 💬
|
96 | CAT-1004 | - | - | - | - | 1件: 113 113 💬
|
97 | Chronic corticosteroid therapy | - | - | - | - | 1件: 113 113 💬
|
98 | Cialis 10 MG FILM-coated tablets | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 2件: 86 86, 113 💬
|
99 | Cialis 2.5 MG FILM-coated tablets | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 2件: 86 86, 113 💬
|
100 | Cialis 20 MG FILM-coated tablets | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 2件: 86 86, 113 💬
|
101 | Cialis 5 MG FILM-coated tablets | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 2件: 86 86, 113 💬
|
102 | Citrulline | 1件: Citrulline Citrulline | 2件: L-Citrulline
L-Citrulline
,
Citrulline malate
💬
| - | - | 1件: 113 113 💬
|
103 | Clenbuterol | 1件: Clenbuterol Clenbuterol | 2件: Clenbuterol hydrochloride
Clenbuterol hydrochloride
,
Clenbuterol
💬
| 1件: ADRB2 ADRB2 💬
| 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 4件: 1 1, 2, 113, 256 💬
|
104 | Coenzyme Q10 | 1件: Ubidecarenone Ubidecarenone | 1件: Ubidecarenone
Ubidecarenone
💬
| - | - | 12件: 2 2, 5, 6, 8, 10, 46, 57, 107, 113, 193, 214, 215 💬
|
105 | Coenzyme Q10 and lisinopril | 1件: Ubidecarenone Ubidecarenone | 1件: Ubidecarenone
Ubidecarenone
💬
| - | - | 1件: 113 113 💬
|
106 | Complete physical examination | - | - | - | - | 1件: 113 113 💬
|
107 | Concurrent exercise training | - | - | - | - | 1件: 113 113 💬
|
108 | Control group typically developing | - | - | - | - | 1件: 113 113 💬
|
109 | Corticosteroid | - | - | - | - | 7件: 13 13, 66, 84, 96, 97, 113, 222 💬
|
110 | Corticosteroide | - | - | - | - | 1件: 113 113 💬
|
111 | Corticosteroids | - | - | - | - | 12件: 41 41, 46, 49, 63, 64, 97, 107, 113, 164, 220, 296, 300 💬
|
112 | Cosintropina acetato | - | - | - | - | 1件: 113 113 💬
|
113 | Cosyntropin | 1件: Tetracosactide Tetracosactide | 2件: Cosyntropin
Cosyntropin
,
Tetracosactide acetate
💬
| 1件: MC2R MC2R 💬
| 6件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 113 113 💬
|
114 | Cosyntropin acetate | 1件: Tetracosactide Tetracosactide | 2件: Cosyntropin
Cosyntropin
,
Tetracosactide acetate
💬
| 1件: MC2R MC2R 💬
| 6件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 113 113 💬
|
115 | CR13C | - | - | - | - | 1件: 113 113 💬
|
116 | CRD-TMH-001 | - | - | - | - | 1件: 113 113 💬
|
117 | CRD007 | - | - | - | - | 1件: 113 113 💬
|
118 | Creatine monohydrate | 1件: Creatine Creatine | - | - | - | 5件: 2 2, 8, 97, 113, 156 💬
|
119 | Creatine-13C | 1件: Creatine Creatine | - | - | - | 1件: 113 113 💬
|
120 | Cyclosporin A | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 11件: 46 46, 49, 53, 54, 56, 60, 62, 93, 95, 113, 164 💬
|
121 | Decortin | - | - | - | - | 2件: 46 46, 113 💬
|
122 | Deflan*10CPR 6MG | - | - | - | - | 1件: 113 113 💬
|
123 | Deflazacort | 1件: Deflazacort Deflazacort | 1件: Deflazacort
Deflazacort
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 30 30, 113 💬
|
124 | Deflazacort 6 MG tablets | 1件: Deflazacort Deflazacort | 1件: Deflazacort
Deflazacort
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 113 113 💬
|
125 | Dehydroepiandrosterone 100 and 400 MG | 1件: Prasterone Prasterone | 1件: Prasterone
Prasterone
💬
| 3件: AR AR, ESR1, ESR2 💬
| 12件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 113 113 💬
|
126 | Delandistrogene moxeparvovec | 1件: Delandistrogene moxeparvovec Delandistrogene moxeparvovec | 1件: Delandistrogene moxeparvovec
Delandistrogene moxeparvovec
💬
| 1件: DMD DMD 💬
| 5件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬 | 1件: 113 113 💬
|
127 | Deltacortene*20CPR 5MG | - | - | - | - | 3件: 49 49, 97, 113 💬
|
128 | Dexmedetomidine | 1件: Dexmedetomidine Dexmedetomidine | 2件: Dexmedetomidine
Dexmedetomidine
,
Dexmedetomidine hydrochloride
💬
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| 4件: Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 15件: 2 2, 4, 6, 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
|
129 | Dilatrend | - | - | - | - | 1件: 113 113 💬
|
130 | DM1-activc | - | - | - | - | 1件: 113 113 💬
|
131 | Dosing extension | - | - | - | - | 1件: 113 113 💬
|
132 | Drisapersen | 1件: Drisapersen Drisapersen | 1件: Drisapersen
Drisapersen
💬
| 1件: DMD DMD 💬
| 5件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬 | 1件: 113 113 💬
|
133 | Drisapersen sodium | 1件: Drisapersen Drisapersen | 1件: Drisapersen
Drisapersen
💬
| 1件: DMD DMD 💬
| 5件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬 | 1件: 113 113 💬
|
134 | DS-5141B | - | - | - | - | 1件: 113 113 💬
|
135 | DT-DEC01 | 1件: DT-DEC01 DT-DEC01 | - | - | - | 1件: 113 113 💬
|
136 | Duchenne muscular dystrophy group with deflazacort | - | - | - | - | 1件: 113 113 💬
|
137 | Duchenne muscular dystrophy group with prednisone/predisolone | - | - | - | - | 1件: 113 113 💬
|
138 | Duchenne muscular dystrophy group without corticosteroids therapy | - | - | - | - | 1件: 113 113 💬
|
139 | DYNE-101 | - | - | - | - | 1件: 113 113 💬
|
140 | DYNE-251 | 1件: DYNE-251 DYNE-251 | - | - | - | 1件: 113 113 💬
|
141 | Dystrophin levels | - | - | - | - | 1件: 113 113 💬
|
142 | Edasalonexent | 1件: Edasalonexent Edasalonexent | 1件: Edasalonexent
Edasalonexent
💬
| 1件: RELA RELA 💬
| 75件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Apoptosis, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Chronic myeloid leukemia, Cocaine addiction, Coronavirus disease - COVID-19, Cytosolic DNA-sensing pathway, Diabetic cardiomyopathy, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fluid shear stress and atherosclerosis, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Longevity regulating pathway, MAPK signaling pathway, Measles, Mitophagy - animal, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prolactin signaling pathway, Prostate cancer, RIG-I-like receptor signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway 💬 | 1件: 113 113 💬
|
143 | EMD 87580 | - | - | - | - | 1件: 113 113 💬
|
144 | Emea/H/C/000638 | - | - | - | - | 1件: 113 113 💬
|
145 | Empagliflozin tablets | 1件: Empagliflozin Empagliflozin | 1件: Empagliflozin
Empagliflozin
💬
| - | - | 1件: 113 113 💬
|
146 | EN001 | - | - | - | - | 2件: 10 10, 113 💬
|
147 | Enahexal®, 10MG | - | - | - | - | 1件: 113 113 💬
|
148 | Enalapril | 1件: Enalapril Enalapril | 2件: Enalapril maleate
Enalapril maleate
,
Enalapril
💬
| 1件: ACE ACE 💬
| 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 6件: 13 13, 66, 113, 210, 222, 279 💬
|
149 | Enalhexal®, 5 MG | - | - | - | - | 1件: 113 113 💬
|
150 | END-OF-life nursing education consortium-pediatric palliative care AS WEB based-training plus usual care | - | - | - | - | 2件: 113 113, 299 💬
|
151 | EPA and DHA | - | - | - | - | 1件: 113 113 💬
|
152 | EPI-321 | - | - | - | - | 1件: 113 113 💬
|
153 | Epicatechin | 1件: Epicatechin Epicatechin | - | - | - | 2件: 86 86, 113 💬
|
154 | Epigallocatechin-gallate | 1件: Epigallocatechin Epigallocatechin | - | - | - | 1件: 113 113 💬
|
155 | Eplerenone | 1件: Eplerenone Eplerenone | 1件: Eplerenone
Eplerenone
💬
| 1件: NR3C2 NR3C2 💬
| 1件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption 💬 | 4件: 75 75, 113, 210, 215 💬
|
156 | ERX-963 | - | - | - | - | 1件: 113 113 💬
|
157 | Esomeprazole | 1件: Esomeprazole Esomeprazole | 5件: Esomeprazole magnesium
Esomeprazole magnesium
,
Esomeprazole sodium
,
Esomeprazole
,
Esomeprazole strontium
,
Esomeprazole magnesium dihydrate
💬
| 2件: ATP4A ATP4A, ATP4B 💬
| 3件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | 9件: 6 6, 13, 46, 86, 98, 107, 113, 298, 299 💬
|
158 | Esomeprazolo | - | - | - | - | 1件: 113 113 💬
|
159 | Eteplirsen | 1件: Eteplirsen Eteplirsen | 1件: Eteplirsen
Eteplirsen
💬
| 1件: DMD DMD 💬
| 5件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬 | 1件: 113 113 💬
|
160 | Eteplirsen injection | 1件: Eteplirsen Eteplirsen | 1件: Eteplirsen
Eteplirsen
💬
| 1件: DMD DMD 💬
| 5件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬 | 1件: 113 113 💬
|
161 | Eucardic | - | - | - | - | 1件: 113 113 💬
|
162 | EV substance code: SUB188638 | - | - | - | - | 1件: 113 113 💬
|
163 | Exercise training | - | - | - | - | 2件: 113 113, 265 💬
|
164 | Exondys 51 | 1件: Eteplirsen Eteplirsen | 1件: Eteplirsen
Eteplirsen
💬
| 1件: DMD DMD 💬
| 5件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬 | 1件: 113 113 💬
|
165 | Ezutromid | 1件: Ezutromid Ezutromid | - | - | - | 1件: 113 113 💬
|
166 | Fatigue and daytime sleepiness scale | - | - | - | - | 1件: 113 113 💬
|
167 | FG-3019 | - | - | - | - | 3件: 85 85, 113, 222 💬
|
168 | Filgrastim | 1件: Filgrastim Filgrastim | 1件: Filgrastim
Filgrastim
💬
| 1件: CSF3R CSF3R 💬
| 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 29件: 2 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 47, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
|
169 | Flavocoxid | - | - | - | - | 1件: 113 113 💬
|
170 | Fordadistrogene movaparvovec | 1件: Fordadistrogene movaparvovec Fordadistrogene movaparvovec | - | - | - | 1件: 113 113 💬
|
171 | Fragment antibody targeting human TFR1 conjugated TO phosphorodiamidate morpholino oligomer | - | - | - | - | 1件: 113 113 💬
|
172 | FTX-1821 | - | - | - | - | 1件: 113 113 💬
|
173 | Functional index-2 | - | - | - | - | 1件: 113 113 💬
|
174 | GEN6050X intravenous injection | - | - | - | - | 1件: 113 113 💬
|
175 | Genetic characterization | - | - | - | - | 1件: 113 113 💬
|
176 | Gentamicin | 1件: Gentamicin Gentamicin | 2件: Gentamicin sulfate
Gentamicin sulfate
,
Gentamicin
💬
| - | - | 3件: 36 36, 113, 299 💬
|
177 | Gentamicin infusions twice A week FOR SIX months | 1件: Gentamicin Gentamicin | 2件: Gentamicin sulfate
Gentamicin sulfate
,
Gentamicin
💬
| - | - | 1件: 113 113 💬
|
178 | Givinostat | 1件: Givinostat Givinostat | 1件: Givinostat
Givinostat
💬
| 11件: HDAC10 HDAC10, HDAC11, HDAC1_2, HDAC1_2, HDAC3, HDAC4_5, HDAC4_5, HDAC6, HDAC7, HDAC8, HDAC9 💬
| 20件: ATP-dependent chromatin remodeling ATP-dependent chromatin remodeling, Alcoholism, Amphetamine addiction, Amyotrophic lateral sclerosis, Apelin signaling pathway, Cell cycle, Chronic myeloid leukemia, Epstein-Barr virus infection, Human papillomavirus infection, Huntington disease, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, Notch signaling pathway, Pathways in cancer, Polycomb repressive complex, TGF-beta signaling pathway, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Viral carcinogenesis 💬 | 2件: 107 107, 113 💬
|
179 | Givinostat hydrochloride - cohort 2 | 1件: Givinostat Givinostat | 1件: Givinostat
Givinostat
💬
| 11件: HDAC10 HDAC10, HDAC11, HDAC1_2, HDAC1_2, HDAC3, HDAC4_5, HDAC4_5, HDAC6, HDAC7, HDAC8, HDAC9 💬
| 20件: ATP-dependent chromatin remodeling ATP-dependent chromatin remodeling, Alcoholism, Amphetamine addiction, Amyotrophic lateral sclerosis, Apelin signaling pathway, Cell cycle, Chronic myeloid leukemia, Epstein-Barr virus infection, Human papillomavirus infection, Huntington disease, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, Notch signaling pathway, Pathways in cancer, Polycomb repressive complex, TGF-beta signaling pathway, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Viral carcinogenesis 💬 | 1件: 113 113 💬
|
180 | Glucocorticoid | - | - | - | - | 6件: 46 46, 49, 66, 113, 220, 228 💬
|
181 | Glutamine | 1件: L-Glutamine L-Glutamine | 1件: Glutamine
Glutamine
💬
| - | - | 10件: 87 87, 89, 96, 97, 113, 214, 215, 222, 245, 299 💬
|
182 | GNT0004 | - | - | - | - | 1件: 113 113 💬
|
183 | GNT0006 | - | - | - | - | 1件: 113 113 💬
|
184 | Golodirsen | 1件: Golodirsen Golodirsen | 1件: Golodirsen
Golodirsen
💬
| 1件: DMD DMD 💬
| 5件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬 | 1件: 113 113 💬
|
185 | Growth hormone | 1件: Somatotropin Somatotropin | 1件: Somatropin
Somatropin
💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 16件: 2 2, 19, 46, 77, 78, 96, 97, 107, 113, 156, 191, 193, 195, 238, 265, 299 💬
|
186 | Gsgc | - | - | - | - | 1件: 113 113 💬
|
187 | GSK2402968 | - | - | - | - | 1件: 113 113 💬
|
188 | GSK2402968 3MG/KG/week | - | - | - | - | 1件: 113 113 💬
|
189 | GSK2402968 6 MG/KG/week | - | - | - | - | 1件: 113 113 💬
|
190 | GSK2402968 6MG/KG/week | - | - | - | - | 1件: 113 113 💬
|
191 | GYM329 | 1件: GYM329 GYM329 | - | - | - | 2件: 3 3, 113 💬
|
192 | H44aon188 | - | - | - | - | 1件: 113 113 💬
|
193 | H51aon23 | - | - | - | - | 1件: 113 113 💬
|
194 | Haemostasis tests | - | - | - | - | 1件: 113 113 💬
|
195 | Hand opening time | - | - | - | - | 1件: 113 113 💬
|
196 | HG302 | - | - | - | - | 1件: 113 113 💬
|
197 | Hidroferol | - | - | - | - | 1件: 113 113 💬
|
198 | HLA-identical allogeneic mesoangioblasts | - | - | - | - | 1件: 113 113 💬
|
199 | Hmabs | - | - | - | - | 1件: 113 113 💬
|
200 | Hormonal profile | - | - | - | - | 1件: 113 113 💬
|
201 | HT-100 | - | - | - | - | 1件: 113 113 💬
|
202 | Human umbilical cord mesenchymal stem cells | 1件: Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | 4件: 13 13, 96, 113, 271 💬
|
203 | Ibuprofen | 1件: Ibuprofen Ibuprofen | 5件: Ibuprofen
Ibuprofen
,
Ibuprofen aluminum
,
Ibuprofen lysine
,
Ibuprofen sodium
,
Ibuprofen sodium
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 6件: 13 13, 46, 65, 113, 271, 299 💬
|
204 | Ibuprofen and isosorbide dinitrate combination | 1件: Ibuprofen Ibuprofen | 5件: Ibuprofen
Ibuprofen
,
Ibuprofen aluminum
,
Ibuprofen lysine
,
Ibuprofen sodium
,
Ibuprofen sodium
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 113 113 💬
|
205 | Idebenone | 1件: Idebenone Idebenone | 1件: Idebenone
Idebenone
💬
| - | - | 7件: 6 6, 8, 13, 18, 21, 113, 302 💬
|
206 | Idebenone 150 MG FILM-coated tablets | 1件: Idebenone Idebenone | 1件: Idebenone
Idebenone
💬
| - | - | 1件: 113 113 💬
|
207 | Idefirix | 1件: Imlifidase Imlifidase | 1件: Imlifidase
Imlifidase
💬
| - | - | 3件: 43 43, 44, 113 💬
|
208 | Ifetroban | 1件: Ifetroban Ifetroban | 2件: Ifetroban
Ifetroban
,
Ifetroban sodium
💬
| 1件: TBXA2R TBXA2R 💬
| 3件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation 💬 | 1件: 113 113 💬
|
209 | IGF-1 | - | - | - | - | 1件: 113 113 💬
|
210 | Imlifidase | 1件: Imlifidase Imlifidase | 1件: Imlifidase
Imlifidase
💬
| - | - | 4件: 43 43, 44, 113, 221 💬
|
211 | IN-home exercise training | - | - | - | - | 1件: 113 113 💬
|
212 | Increased exercise intensity | - | - | - | - | 1件: 113 113 💬
|
213 | Inflammatory profile | - | - | - | - | 1件: 113 113 💬
|
214 | INS1201 | - | - | - | - | 1件: 113 113 💬
|
215 | Ionis-dmpkrx | - | - | - | - | 1件: 113 113 💬
|
216 | Isosorbide dinitrate 20 MG | 2件: Isosorbide Isosorbide, Isosorbide dinitrate | 2件: Isosorbide
Isosorbide
,
Isosorbide dinitrate
💬
| - | - | 1件: 113 113 💬
|
217 | Isosorbide dinitrate 40 MG | 2件: Isosorbide Isosorbide, Isosorbide dinitrate | 2件: Isosorbide
Isosorbide
,
Isosorbide dinitrate
💬
| - | - | 1件: 113 113 💬
|
218 | Isosorbide dinitrate 60 MG | 2件: Isosorbide Isosorbide, Isosorbide dinitrate | 2件: Isosorbide
Isosorbide
,
Isosorbide dinitrate
💬
| - | - | 1件: 113 113 💬
|
219 | Isosorbide dinitrate 80 MG | 2件: Isosorbide Isosorbide, Isosorbide dinitrate | 2件: Isosorbide
Isosorbide
,
Isosorbide dinitrate
💬
| - | - | 1件: 113 113 💬
|
220 | ITF2357 | - | - | - | - | 4件: 96 96, 107, 113, 267 💬
|
221 | ITF2357 10 MG/ML | - | - | - | - | 1件: 113 113 💬
|
222 | IV infusion | - | - | - | - | 1件: 113 113 💬
|
223 | JWK007 single intravenous infusion administration | - | - | - | - | 1件: 113 113 💬
|
224 | Ketamine | 1件: Ketamine Ketamine | 2件: Ketamine hydrochloride
Ketamine hydrochloride
,
Ketamine
💬
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 6件: 6 6, 13, 70, 113, 156, 215 💬
|
225 | L-arginine | 1件: L-arginine L-arginine | - | - | - | 5件: 2 2, 21, 46, 113, 299 💬
|
226 | L-citrulline and metformin & L-citrulline | 1件: Metformin Metformin | 2件: Metformin hydrochloride
Metformin hydrochloride
,
Metformin
💬
| 2件: PRKAA PRKAA, PRKAA 💬
| 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 113 113 💬
|
227 | L-glutamine | 1件: L-Glutamine L-Glutamine | 1件: Glutamine
Glutamine
💬
| - | - | 2件: 113 113, 299 💬
|
228 | Laboratory tests | - | - | - | - | 3件: 19 19, 113, 256 💬
|
229 | Lamotrigin actavis | - | - | - | - | 2件: 113 113, 114 💬
|
230 | Lamotrigine | 1件: Lamotrigine Lamotrigine | 1件: Lamotrigine
Lamotrigine
💬
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬
| 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 5件: 13 13, 34, 113, 114, 144 💬
|
231 | LE051 | - | - | - | - | 1件: 113 113 💬
|
232 | Lentiviral vector trans-skip gene modified autologous mesoangioblasts | - | - | - | - | 1件: 113 113 💬
|
233 | Lisinopril | 1件: Lisinopril Lisinopril | 2件: Lisinopril
Lisinopril
,
Lisinopril
💬
| 1件: ACE ACE 💬
| 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 5件: 19 19, 46, 66, 67, 113 💬
|
234 | Lonafarnib | 1件: Lonafarnib Lonafarnib | 1件: Lonafarnib
Lonafarnib
💬
| 2件: FNTA FNTA, FNTB 💬
| 1件: Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis 💬 | 2件: 113 113, 333 💬
|
235 | Losartan | 1件: Losartan Losartan | 2件: Losartan potassium
Losartan potassium
,
Losartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 15件: 17 17, 19, 46, 58, 66, 67, 85, 96, 97, 113, 164, 167, 215, 222, 299 💬
|
236 | Losmapimod | 1件: Losmapimod Losmapimod | 1件: Losmapimod
Losmapimod
💬
| 4件: P38 P38, P38, P38, P38 💬
| 62件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Alcoholic liver disease, Amyotrophic lateral sclerosis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Dopaminergic synapse, Efferocytosis, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hepatitis B, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, IL-17 signaling pathway, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Oocyte meiosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rap1 signaling pathway, Relaxin signaling pathway, Retrograde endocannabinoid signaling, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thermogenesis, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Yersinia infection 💬 | 2件: 113 113, 222 💬
|
237 | Lucen | - | - | - | - | 1件: 113 113 💬
|
238 | Magnesio | 1件: Magnesium Magnesium | - | - | - | 1件: 113 113 💬
|
239 | Magnesium oxide | 2件: Magnesium Magnesium, Magnesium oxide | 1件: Magnesium oxide
Magnesium oxide
💬
| - | - | 3件: 6 6, 113, 166 💬
|
240 | Mannitol | 1件: Mannitol Mannitol | 1件: Mannitol
Mannitol
💬
| - | - | 6件: 6 6, 13, 60, 96, 113, 299 💬
|
241 | Manual muscle testing | - | - | - | - | 1件: 113 113 💬
|
242 | Mcgill pain questionnaire | - | - | - | - | 1件: 113 113 💬
|
243 | Metabolic profile | - | - | - | - | 1件: 113 113 💬
|
244 | Metformin | 1件: Metformin Metformin | 2件: Metformin hydrochloride
Metformin hydrochloride
,
Metformin
💬
| 2件: PRKAA PRKAA, PRKAA 💬
| 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 23件: 2 2, 6, 8, 13, 46, 49, 60, 65, 66, 67, 75, 77, 84, 86, 97, 113, 127, 206, 218, 225, 265, 285, 298 💬
|
245 | Metformin 500MG | 1件: Metformin Metformin | 2件: Metformin hydrochloride
Metformin hydrochloride
,
Metformin
💬
| 2件: PRKAA PRKAA, PRKAA 💬
| 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 113 113 💬
|
246 | Metformin and metformin & L-citrulline | 1件: Metformin Metformin | 2件: Metformin hydrochloride
Metformin hydrochloride
,
Metformin
💬
| 2件: PRKAA PRKAA, PRKAA 💬
| 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 113 113 💬
|
247 | Metformina - 500 30 compresse 500 MG | 1件: Metformin Metformin | 2件: Metformin hydrochloride
Metformin hydrochloride
,
Metformin
💬
| 2件: PRKAA PRKAA, PRKAA 💬
| 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 113 113 💬
|
248 | Methylphenidate | 1件: Methylphenidate Methylphenidate | 2件: Methylphenidate hydrochloride
Methylphenidate hydrochloride
,
Methylphenidate
💬
| 2件: SLC6A2 SLC6A2, SLC6A3 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 5件: 6 6, 13, 34, 84, 113 💬
|
249 | Metohexal® succ ® 23,75 MG retardtabletten | - | - | - | - | 1件: 113 113 💬
|
250 | Metohexal® succ ® 47,5 MG retardtabletten | - | - | - | - | 1件: 113 113 💬
|
251 | Metohexal® succ ® 95 MG retardtabletten | - | - | - | - | 1件: 113 113 💬
|
252 | Metoprolol | 1件: Metoprolol Metoprolol | 4件: Metoprolol tartrate
Metoprolol tartrate
,
Metoprolol succinate
,
Metoprolol
,
Metoprolol fumarate
💬
| 1件: ADRB1 ADRB1 💬
| 13件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 57 57, 58, 113 💬
|
253 | Metoprolol succinate | 1件: Metoprolol Metoprolol | 4件: Metoprolol tartrate
Metoprolol tartrate
,
Metoprolol succinate
,
Metoprolol
,
Metoprolol fumarate
💬
| 1件: ADRB1 ADRB1 💬
| 13件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 58 58, 113, 193 💬
|
254 | Mexiletine | 1件: Mexiletine Mexiletine | 2件: Mexiletine hydrochloride
Mexiletine hydrochloride
,
Mexiletine
💬
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬
| 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 4件: 2 2, 10, 113, 114 💬
|
255 | Mexiletine 167 MG | 1件: Mexiletine Mexiletine | 2件: Mexiletine hydrochloride
Mexiletine hydrochloride
,
Mexiletine
💬
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬
| 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 113 113 💬
|
256 | Mexiletine granules FOR prolonged-release oral suspension | 1件: Mexiletine Mexiletine | 2件: Mexiletine hydrochloride
Mexiletine hydrochloride
,
Mexiletine
💬
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬
| 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 113 113 💬
|
257 | MNK-1411 | - | - | - | - | 1件: 113 113 💬
|
258 | Monocytes and megacaryocytes culture and RNA extraction | - | - | - | - | 1件: 113 113 💬
|
259 | Motor function scales | - | - | - | - | 1件: 113 113 💬
|
260 | Motor milestone assessments | - | - | - | - | 1件: 113 113 💬
|
261 | Moxifloxacin hydrochloride | 1件: Moxifloxacin Moxifloxacin | 3件: Moxifloxacin hydrochloride
Moxifloxacin hydrochloride
,
Moxifloxacin
,
Moxifloxacin hydrochloride monohydrate
💬
| - | - | 2件: 113 113, 299 💬
|
262 | MULT-ingredient supplement | - | - | - | - | 1件: 113 113 💬
|
263 | Muscle elastography | - | - | - | - | 1件: 113 113 💬
|
264 | Muscle ultrasound | - | - | - | - | 4件: 3 3, 15, 113, 256 💬
|
265 | MYO-029 | 1件: Stamulumab Stamulumab | 1件: Stamulumab
Stamulumab
💬
| 1件: MSTN MSTN 💬
| 1件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | 1件: 113 113 💬
|
266 | Myoblast autologous graft | - | - | - | - | 1件: 113 113 💬
|
267 | Myoblast transplantation | - | - | - | - | 1件: 113 113 💬
|
268 | Myoblastes autologues | - | - | - | - | 1件: 113 113 💬
|
269 | Myodm | - | - | - | - | 1件: 113 113 💬
|
270 | Myopaxon | - | - | - | - | 1件: 113 113 💬
|
271 | Myotonia behaviour scale | - | - | - | - | 1件: 113 113 💬
|
272 | N(4,5BIS methanesulfonyl2methylbenzoyl) guanidine hydrochloride monohydrate | - | - | - | - | 1件: 113 113 💬
|
273 | N-(4,5-BIS methanesulfonyl-2-methyl-benzoyl)guanidine hydrochloride monohydrate | - | - | - | - | 1件: 113 113 💬
|
274 | Nebivolol | 1件: Nebivolol Nebivolol | 2件: Nebivolol
Nebivolol
,
Nebivolol hydrochloride
💬
| 1件: ADRB1 ADRB1 💬
| 13件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 85 85, 113, 167 💬
|
275 | Needle biopsy OF THE vastus lateralis muscle | - | - | - | - | 1件: 113 113 💬
|
276 | NON invasive prenatal diagnosis | - | - | - | - | 3件: 8 8, 113, 206 💬
|
277 | NPC-14 | - | - | - | - | 1件: 113 113 💬
|
278 | NS-050/NCNP-03 | - | - | - | - | 1件: 113 113 💬
|
279 | NS-065/NCNP-01 | - | - | - | - | 1件: 113 113 💬
|
280 | NS-089/NCNP-02 | - | - | - | - | 1件: 113 113 💬
|
281 | Nébivolol | - | - | - | - | 1件: 113 113 💬
|
282 | Oligomero morfolino fosforodiamidato PER skipping dell’esone 45 | - | - | - | - | 1件: 113 113 💬
|
283 | Oligomero morfolino fosforodiamidato PER skipping dell’esone 53 | - | - | - | - | 1件: 113 113 💬
|
284 | Omigapil | 1件: Omigapil Omigapil | - | - | - | 1件: 113 113 💬
|
285 | Oromotor function and nutrition | - | - | - | - | 1件: 113 113 💬
|
286 | Oxatomide | 1件: Oxatomide Oxatomide | 1件: Oxatomide
Oxatomide
💬
| 1件: ALOX5 ALOX5 💬
| 6件: Arachidonic acid metabolism Arachidonic acid metabolism, Efferocytosis, Fc epsilon RI signaling pathway, Ovarian steroidogenesis, Serotonergic synapse, Toxoplasmosis 💬 | 1件: 113 113 💬
|
287 | P-188 NF | - | - | - | - | 1件: 113 113 💬
|
288 | Pamrevlumab | 1件: Pamrevlumab Pamrevlumab | 1件: Pamrevlumab
Pamrevlumab
💬
| 1件: CTGF CTGF 💬
| 2件: Apelin signaling pathway Apelin signaling pathway, Hippo signaling pathway 💬 | 2件: 85 85, 113 💬
|
289 | PB1046 injection | - | - | - | - | 1件: 113 113 💬
|
290 | Pemirolast | 1件: Pemirolast Pemirolast | 2件: Pemirolast potassium
Pemirolast potassium
,
Pemirolast
💬
| - | - | 1件: 113 113 💬
|
291 | Pending | - | - | - | - | 7件: 6 6, 13, 19, 96, 97, 113, 302 💬
|
292 | Pentoxifylline | 1件: Pentoxifylline Pentoxifylline | 1件: Pentoxifylline
Pentoxifylline
💬
| - | - | 11件: 26 26, 56, 84, 93, 96, 97, 113, 220, 222, 296, 298 💬
|
293 | Peptide-conjugated phosphorodiamidate morpholino oligomer FOR exon 51 skipping | - | - | - | - | 1件: 113 113 💬
|
294 | Peptide-conjugated phosphorodiamide morpholino oligomer FOR exon 51 skipping | - | - | - | - | 1件: 113 113 💬
|
295 | Perindopril | 1件: Perindopril Perindopril | 3件: Perindopril erbumine
Perindopril erbumine
,
Perindopril
,
Perindopril arginine
💬
| 1件: ACE ACE 💬
| 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 3件: 113 113, 167, 222 💬
|
296 | Perindopril 2MG tablets | 1件: Perindopril Perindopril | 3件: Perindopril erbumine
Perindopril erbumine
,
Perindopril
,
Perindopril arginine
💬
| 1件: ACE ACE 💬
| 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 1件: 113 113 💬
|
297 | PF-06252616 | 1件: Domagrozumab Domagrozumab | 1件: Domagrozumab
Domagrozumab
💬
| 1件: MSTN MSTN 💬
| 1件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | 1件: 113 113 💬
|
298 | PF-06939926 | - | - | - | - | 1件: 113 113 💬
|
299 | PGN-EDO51 | - | - | - | - | 1件: 113 113 💬
|
300 | PGN-edodm1 | - | - | - | - | 1件: 113 113 💬
|
301 | PGN-edodm1 FOR infusion | - | - | - | - | 1件: 113 113 💬
|
302 | Phase 1, SQY51 | - | - | - | - | 1件: 113 113 💬
|
303 | Phosphorodiamidate morpholino oligomer | - | - | - | - | 1件: 113 113 💬
|
304 | Phosphorodiamidate morpholino oligomer FOR exon 45 skipping | - | - | - | - | 1件: 113 113 💬
|
305 | Phosphorodiamidate morpholino oligomer FOR exon 53 skipping | - | - | - | - | 1件: 113 113 💬
|
306 | Pitolisant oral tablet | 1件: Pitolisant Pitolisant | 2件: Pitolisant
Pitolisant
,
Pitolisant hydrochloride
💬
| 1件: HRH3 HRH3 💬
| 2件: Neuroactive ligand signaling Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 113 113 💬
|
307 | Plasmapheresis | - | - | - | - | 4件: 11 11, 49, 113, 222 💬
|
308 | PRD2175434 | - | - | - | - | 1件: 113 113 💬
|
309 | Prednisolone | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 38件: 3 3, 11, 13, 14, 18, 25, 26, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 54, 56, 60, 63, 64, 66, 81, 84, 85, 96, 97, 113, 145, 162, 222, 251, 269, 271, 296, 299, 300 💬
|
310 | Prednison | - | - | - | - | 4件: 46 46, 84, 113, 300 💬
|
311 | Prednisone | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 54件: 2 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 145, 162, 164, 205, 222, 224, 228, 251, 269, 283, 285, 288, 299, 300, 303, 307, 331 💬
|
312 | Prednisone 5 MG tablets | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 113 113 💬
|
313 | Prednisone plus exercise | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 113 113 💬
|
314 | Pressure pain threshold | - | - | - | - | 4件: 3 3, 15, 113, 256 💬
|
315 | Primidone | 1件: Primidone Primidone | 1件: Primidone
Primidone
💬
| - | - | 2件: 2 2, 113 💬
|
316 | PRO044 | 1件: BMN-044 BMN-044 | - | - | - | 1件: 113 113 💬
|
317 | PRO044 IV | 1件: BMN-044 BMN-044 | - | - | - | 1件: 113 113 💬
|
318 | PRO044 IV 6 MG/KG | 1件: BMN-044 BMN-044 | - | - | - | 1件: 113 113 💬
|
319 | PRO044 IV 9 MG/KG | 1件: BMN-044 BMN-044 | - | - | - | 1件: 113 113 💬
|
320 | PRO044 SC | 1件: BMN-044 BMN-044 | - | - | - | 1件: 113 113 💬
|
321 | PRO044 SC 6 MG/KG | 1件: BMN-044 BMN-044 | - | - | - | 1件: 113 113 💬
|
322 | PRO045 | 1件: BMN-045 BMN-045 | - | - | - | 1件: 113 113 💬
|
323 | PRO045, 0.15 MG/KG/week | 1件: BMN-045 BMN-045 | - | - | - | 1件: 113 113 💬
|
324 | PRO045, 1.0 MG/KG/week | 1件: BMN-045 BMN-045 | - | - | - | 1件: 113 113 💬
|
325 | PRO045, 3.0 MG/KG/week | 1件: BMN-045 BMN-045 | - | - | - | 1件: 113 113 💬
|
326 | PRO045, 6.0 MG/KG/week | 1件: BMN-045 BMN-045 | - | - | - | 1件: 113 113 💬
|
327 | PRO045, 9.0 MG/KG/week | 1件: BMN-045 BMN-045 | - | - | - | 1件: 113 113 💬
|
328 | PRO045, selected dose | 1件: BMN-045 BMN-045 | - | - | - | 1件: 113 113 💬
|
329 | PRO051 | - | - | - | - | 1件: 113 113 💬
|
330 | PRO053 | 1件: BMN-053 BMN-053 | - | - | - | 1件: 113 113 💬
|
331 | Protein-carbohydrate supplementation | - | - | - | - | 1件: 113 113 💬
|
332 | Provigil - 100 MG compresse 30 compresse | - | - | - | - | 1件: 113 113 💬
|
333 | PS188 | - | - | - | - | 1件: 113 113 💬
|
334 | PS220 | - | - | - | - | 1件: 113 113 💬
|
335 | PS524 | - | - | - | - | 1件: 113 113 💬
|
336 | PTC0161480, PTC124 compound 1A, RPS2505, PTC-C124, 291844 | - | - | - | - | 1件: 113 113 💬
|
337 | PTC124 | - | - | - | - | 4件: 19 19, 113, 246, 299 💬
|
338 | Quantitative muscle testing | - | - | - | - | 1件: 113 113 💬
|
339 | Quick motor function test | - | - | - | - | 4件: 3 3, 15, 113, 256 💬
|
340 | R-pact | - | - | - | - | 1件: 113 113 💬
|
341 | RAAV1.CMV.hufollistatin344 | - | - | - | - | 2件: 15 15, 113 💬
|
342 | RAAV1.CMV.hufollistin344 | - | - | - | - | 1件: 113 113 💬
|
343 | RAAV1.tmck.human-alpha-sarcoglycan- first cohort | - | - | - | - | 1件: 113 113 💬
|
344 | RAAV1.tmck.human-alpha-sarcoglycan- second cohort | - | - | - | - | 1件: 113 113 💬
|
345 | RAAV8-HMD1 | - | - | - | - | 1件: 113 113 💬
|
346 | RAAV9-CK8-H-µD5 | 1件: Zildistrogene varoparvovec Zildistrogene varoparvovec | - | - | - | 1件: 113 113 💬
|
347 | RAAV9-hfkrpco_mir-208A | - | - | - | - | 1件: 113 113 💬
|
348 | Raavrh74.MCK.galgt2 | - | - | - | - | 1件: 113 113 💬
|
349 | Raavrh74.MCK.micro-dystrophin | - | - | - | - | 1件: 113 113 💬
|
350 | Ramipril | 1件: Ramipril Ramipril | 1件: Ramipril
Ramipril
💬
| 1件: ACE ACE 💬
| 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 7件: 46 46, 49, 66, 67, 113, 218, 257 💬
|
351 | Ranolazine | 1件: Ranolazine Ranolazine | 2件: Ranolazine
Ranolazine
,
Ranolazine hydrochloride
💬
| - | - | 7件: 2 2, 58, 86, 96, 97, 113, 114 💬
|
352 | Raxone | 1件: Idebenone Idebenone | 1件: Idebenone
Idebenone
💬
| - | - | 2件: 113 113, 302 💬
|
353 | Raxone - 150 MG- compresse rivestite CON FILM- USO orale- flacone (hdpe)- 180 compresse | 1件: Idebenone Idebenone | 1件: Idebenone
Idebenone
💬
| - | - | 1件: 113 113 💬
|
354 | Recombinant human ANTI-GDF-8 antibody | - | - | - | - | 1件: 113 113 💬
|
355 | Regimen selection phase group 2 | - | - | - | - | 1件: 113 113 💬
|
356 | Regimen selection phase group 3 | - | - | - | - | 1件: 113 113 💬
|
357 | Regular exercise | - | - | - | - | 1件: 113 113 💬
|
358 | Renadirsen | 1件: Renadirsen Renadirsen | - | - | - | 1件: 113 113 💬
|
359 | Resveratrol | 1件: Resveratrol Resveratrol | - | - | - | 5件: 8 8, 18, 89, 113, 299 💬
|
360 | Revatio | 1件: Sildenafil Sildenafil | 2件: Sildenafil citrate
Sildenafil citrate
,
Sildenafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 2件: 86 86, 113 💬
|
361 | RGX-202 | 1件: RGX-202 RGX-202 | - | - | - | 1件: 113 113 💬
|
362 | Rhigf-I/rhigfbp-3 | - | - | - | - | 1件: 113 113 💬
|
363 | Ribitol | 1件: Ribitol Ribitol | 1件: Ribitol
Ribitol
💬
| - | - | 1件: 113 113 💬
|
364 | Rimeporide | 1件: Rimeporide Rimeporide | - | - | - | 1件: 113 113 💬
|
365 | Risedronate sodium | 1件: Risedronic acid Risedronic acid | 3件: Risedronate sodium
Risedronate sodium
,
Risedronic acid
,
Risedronate sodium monohydrate
💬
| 1件: FDPS FDPS 💬
| 3件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬 | 4件: 50 50, 107, 113, 274 💬
|
366 | RO720-4239/F01-01 | - | - | - | - | 1件: 113 113 💬
|
367 | RO7204239 | - | - | - | - | 2件: 3 3, 113 💬
|
368 | RO7239361 | - | - | - | - | 1件: 113 113 💬
|
369 | RO7494222 (SRP-9001) | - | - | - | - | 1件: 113 113 💬
|
370 | Saline injection | - | - | - | - | 1件: 113 113 💬
|
371 | Sandimmun optoral | - | - | - | - | 2件: 53 53, 113 💬
|
372 | SAR446268 | - | - | - | - | 1件: 113 113 💬
|
373 | SAT-3247 | - | - | - | - | 1件: 113 113 💬
|
374 | Satralizumab | 1件: Satralizumab Satralizumab | 1件: Satralizumab
Satralizumab
💬
| 1件: IL6R IL6R 💬
| 11件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 4件: 11 11, 13, 86, 113 💬
|
375 | Satralizumab prefilled syringe | 1件: Satralizumab Satralizumab | 1件: Satralizumab
Satralizumab
💬
| 1件: IL6R IL6R 💬
| 11件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 113 113 💬
|
376 | Scaav9.U7.acca | - | - | - | - | 1件: 113 113 💬
|
377 | Scale FOR assessment and rating OF ataxia | - | - | - | - | 1件: 113 113 💬
|
378 | Sevasemten | 1件: Sevasemten Sevasemten | 1件: Sevasemten
Sevasemten
💬
| 8件: MYH1s MYH1s, MYH1s, MYH1s, MYH1s, MYH1s, MYH1s, MYH1s, MYH1s 💬
| 2件: Cytoskeleton in muscle cells Cytoskeleton in muscle cells, Motor proteins 💬 | 1件: 113 113 💬
|
379 | Sevasemten 10 MG | 1件: Sevasemten Sevasemten | 1件: Sevasemten
Sevasemten
💬
| 8件: MYH1s MYH1s, MYH1s, MYH1s, MYH1s, MYH1s, MYH1s, MYH1s, MYH1s 💬
| 2件: Cytoskeleton in muscle cells Cytoskeleton in muscle cells, Motor proteins 💬 | 1件: 113 113 💬
|
380 | Sevasemten 12.5 MG | 1件: Sevasemten Sevasemten | 1件: Sevasemten
Sevasemten
💬
| 8件: MYH1s MYH1s, MYH1s, MYH1s, MYH1s, MYH1s, MYH1s, MYH1s, MYH1s 💬
| 2件: Cytoskeleton in muscle cells Cytoskeleton in muscle cells, Motor proteins 💬 | 1件: 113 113 💬
|
381 | Sevasemten 5 MG | 1件: Sevasemten Sevasemten | 1件: Sevasemten
Sevasemten
💬
| 8件: MYH1s MYH1s, MYH1s, MYH1s, MYH1s, MYH1s, MYH1s, MYH1s, MYH1s 💬
| 2件: Cytoskeleton in muscle cells Cytoskeleton in muscle cells, Motor proteins 💬 | 1件: 113 113 💬
|
382 | Sevasemten dose 1 | 1件: Sevasemten Sevasemten | 1件: Sevasemten
Sevasemten
💬
| 8件: MYH1s MYH1s, MYH1s, MYH1s, MYH1s, MYH1s, MYH1s, MYH1s, MYH1s 💬
| 2件: Cytoskeleton in muscle cells Cytoskeleton in muscle cells, Motor proteins 💬 | 1件: 113 113 💬
|
383 | Sevasemten dose 2 | 1件: Sevasemten Sevasemten | 1件: Sevasemten
Sevasemten
💬
| 8件: MYH1s MYH1s, MYH1s, MYH1s, MYH1s, MYH1s, MYH1s, MYH1s, MYH1s 💬
| 2件: Cytoskeleton in muscle cells Cytoskeleton in muscle cells, Motor proteins 💬 | 1件: 113 113 💬
|
384 | Sevasemten dose 3 | 1件: Sevasemten Sevasemten | 1件: Sevasemten
Sevasemten
💬
| 8件: MYH1s MYH1s, MYH1s, MYH1s, MYH1s, MYH1s, MYH1s, MYH1s, MYH1s 💬
| 2件: Cytoskeleton in muscle cells Cytoskeleton in muscle cells, Motor proteins 💬 | 1件: 113 113 💬
|
385 | Sevasemten dose 4 | 1件: Sevasemten Sevasemten | 1件: Sevasemten
Sevasemten
💬
| 8件: MYH1s MYH1s, MYH1s, MYH1s, MYH1s, MYH1s, MYH1s, MYH1s, MYH1s 💬
| 2件: Cytoskeleton in muscle cells Cytoskeleton in muscle cells, Motor proteins 💬 | 1件: 113 113 💬
|
386 | Sevasemten dose 5 | 1件: Sevasemten Sevasemten | 1件: Sevasemten
Sevasemten
💬
| 8件: MYH1s MYH1s, MYH1s, MYH1s, MYH1s, MYH1s, MYH1s, MYH1s, MYH1s 💬
| 2件: Cytoskeleton in muscle cells Cytoskeleton in muscle cells, Motor proteins 💬 | 1件: 113 113 💬
|
387 | SGT-001 | - | - | - | - | 1件: 113 113 💬
|
388 | SGT-003 | - | - | - | - | 1件: 113 113 💬
|
389 | Sildenafil | 1件: Sildenafil Sildenafil | 2件: Sildenafil citrate
Sildenafil citrate
,
Sildenafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 14件: 6 6, 46, 51, 85, 86, 113, 210, 211, 212, 225, 226, 278, 294, 299 💬
|
390 | SIX minute walking test | - | - | - | - | 1件: 113 113 💬
|
391 | Sleep parameters | - | - | - | - | 1件: 113 113 💬
|
392 | SMT C1100 | - | - | - | - | 1件: 113 113 💬
|
393 | SMT C1100 (F5 | - | - | - | - | 1件: 113 113 💬
|
394 | SMT C1100 (F6 | - | - | - | - | 1件: 113 113 💬
|
395 | SNT-MC17 | - | - | - | - | 1件: 113 113 💬
|
396 | Sodium nitrate | 1件: Sodium nitrate Sodium nitrate | - | - | - | 2件: 58 58, 113 💬
|
397 | Sodium nitrate - double dose | 1件: Sodium nitrate Sodium nitrate | - | - | - | 1件: 113 113 💬
|
398 | Somatokine/iplex | - | - | - | - | 1件: 113 113 💬
|
399 | Somatropin | 1件: Somatotropin Somatotropin | 1件: Somatropin
Somatropin
💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 18件: 2 2, 3, 19, 74, 75, 78, 96, 97, 107, 113, 187, 193, 195, 238, 265, 274, 276, 299 💬
|
400 | Spironolactone | 1件: Spironolactone Spironolactone | 1件: Spironolactone
Spironolactone
💬
| 1件: NR3C2 NR3C2 💬
| 1件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption 💬 | 7件: 46 46, 58, 67, 86, 113, 210, 225 💬
|
401 | SRD-001 | - | - | - | - | 1件: 113 113 💬
|
402 | SRP-4045 | - | - | - | - | 1件: 113 113 💬
|
403 | SRP-4053 | - | - | - | - | 1件: 113 113 💬
|
404 | SRP-5051 | - | - | - | - | 1件: 113 113 💬
|
405 | SRP-6004 | 1件: SRP-6004 SRP-6004 | - | - | - | 1件: 113 113 💬
|
406 | SRP-9001 | - | - | - | - | 1件: 113 113 💬
|
407 | SRP-9003 | - | - | - | - | 1件: 113 113 💬
|
408 | SRP-9004 | - | - | - | - | 1件: 113 113 💬
|
409 | SRP-9005 | 1件: SRP-9005 SRP-9005 | - | - | - | 1件: 113 113 💬
|
410 | Standard steroid treatment | - | - | - | - | 1件: 113 113 💬
|
411 | Stem cell | - | - | - | - | 3件: 2 2, 113, 296 💬
|
412 | Stem cells | - | - | - | - | 5件: 2 2, 4, 46, 96, 113 💬
|
413 | Sunphenon egcg | - | - | - | - | 3件: 13 13, 17, 113 💬
|
414 | Sustanon 250 | - | - | - | - | 1件: 113 113 💬
|
415 | Suvodirsen | 1件: Suvodirsen Suvodirsen | - | - | - | 1件: 113 113 💬
|
416 | Synacthen ampoules 250 MCG | - | - | - | - | 1件: 113 113 💬
|
417 | Synacthen ampoules 250 microgrammi | - | - | - | - | 1件: 113 113 💬
|
418 | Tacrolimus | 1件: Tacrolimus Tacrolimus | 2件: Tacrolimus
Tacrolimus
,
Tacrolimus
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 31件: 2 2, 6, 11, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286 💬
|
419 | Tadalafil | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 7件: 6 6, 51, 75, 77, 84, 86, 113 💬
|
420 | Tadalafil 20 MG | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 113 113 💬
|
421 | Tadalafil and sildenafil | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 113 113 💬
|
422 | Taking OF blood | - | - | - | - | 1件: 113 113 💬
|
423 | Talfirastide | - | - | - | - | 1件: 113 113 💬
|
424 | Tamox | - | - | - | - | 1件: 113 113 💬
|
425 | Tamoxifen | 1件: Tamoxifen Tamoxifen | 2件: Tamoxifen citrate
Tamoxifen citrate
,
Tamoxifen
💬
| 2件: ESR1 ESR1, ESR2 💬
| 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 4件: 2 2, 86, 113, 227 💬
|
426 | Tamoxifen 20MG hexal® filmtabletten | 1件: Tamoxifen Tamoxifen | 2件: Tamoxifen citrate
Tamoxifen citrate
,
Tamoxifen
💬
| 2件: ESR1 ESR1, ESR2 💬
| 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 113 113 💬
|
427 | Tamoxifen citrate | 1件: Tamoxifen Tamoxifen | 2件: Tamoxifen citrate
Tamoxifen citrate
,
Tamoxifen
💬
| 2件: ESR1 ESR1, ESR2 💬
| 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 113 113 💬
|
428 | TAS-205 | - | - | - | - | 1件: 113 113 💬
|
429 | Tehalose 30GR | - | - | - | - | 1件: 113 113 💬
|
430 | Temerit | - | - | - | - | 1件: 113 113 💬
|
431 | Testosterone | 1件: Testosterone Testosterone | 1件: Testosterone
Testosterone
💬
| 1件: AR AR 💬
| 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | 6件: 1 1, 2, 3, 13, 76, 113 💬
|
432 | Testosterone decanoate | 2件: Testosterone Testosterone, Testosterone decanoate | 2件: Testosterone
Testosterone
,
Testosterone decanoate
💬
| 1件: AR AR 💬
| 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | 1件: 113 113 💬
|
433 | Testosterone enanthate | 2件: Testosterone Testosterone, Testosterone enanthate | 2件: Testosterone
Testosterone
,
Testosterone enanthate
💬
| 1件: AR AR 💬
| 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | 1件: 113 113 💬
|
434 | Testosterone isocaproate | 2件: Testosterone Testosterone, Testosterone isocaproate | 1件: Testosterone
Testosterone
💬
| 1件: AR AR 💬
| 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | 1件: 113 113 💬
|
435 | Testosterone phenylpropionate | 2件: Testosterone Testosterone, Testosterone phenylpropionate | 2件: Testosterone
Testosterone
,
Testosterone phenylpropionate
💬
| 1件: AR AR 💬
| 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | 1件: 113 113 💬
|
436 | Testosterone propionate | 2件: Testosterone Testosterone, Testosterone propionate | 2件: Testosterone
Testosterone
,
Testosterone propionate
💬
| 1件: AR AR 💬
| 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | 1件: 113 113 💬
|
437 | Tetracosactide esacetato | 1件: Tetracosactide Tetracosactide | 2件: Cosyntropin
Cosyntropin
,
Tetracosactide acetate
💬
| 1件: MC2R MC2R 💬
| 6件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 113 113 💬
|
438 | Tetracosactide hexaacetate | 1件: Tetracosactide Tetracosactide | 2件: Cosyntropin
Cosyntropin
,
Tetracosactide acetate
💬
| 1件: MC2R MC2R 💬
| 6件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 113 113 💬
|
439 | Tideglusib | 1件: Tideglusib Tideglusib | - | - | - | 3件: 2 2, 5, 113 💬
|
440 | TO BE determined | - | - | - | - | 2件: 96 96, 113 💬
|
441 | Tranilast | 1件: Tranilast Tranilast | 1件: Tranilast
Tranilast
💬
| - | - | 4件: 46 46, 84, 106, 113 💬
|
442 | Translarna | 1件: Ataluren Ataluren | 1件: Ataluren
Ataluren
💬
| - | - | 1件: 113 113 💬
|
443 | Translarna 1000 MG granules FOR oral suspension | 1件: Ataluren Ataluren | 1件: Ataluren
Ataluren
💬
| - | - | 1件: 113 113 💬
|
444 | Translarna 125 MG granules FOR oral suspension | 1件: Ataluren Ataluren | 1件: Ataluren
Ataluren
💬
| - | - | 1件: 113 113 💬
|
445 | Translarna 250 MG granules FOR oral suspension | 1件: Ataluren Ataluren | 1件: Ataluren
Ataluren
💬
| - | - | 1件: 113 113 💬
|
446 | Treatment phase group 4 | - | - | - | - | 1件: 113 113 💬
|
447 | Treatment taken | - | - | - | - | 1件: 113 113 💬
|
448 | Trehalose | 1件: Trehalose Trehalose | - | - | - | 3件: 2 2, 6, 113 💬
|
449 | Triatec | - | - | - | - | 1件: 113 113 💬
|
450 | Triplet-primed PCR or LONG-read sequencing | - | - | - | - | 1件: 113 113 💬
|
451 | Umbilical cord mesenchymal stem cell | - | - | - | - | 1件: 113 113 💬
|
452 | Umbilical cord mesenchymal stem cells | - | - | - | - | 5件: 13 13, 46, 57, 97, 113 💬
|
453 | Vamarolone | - | - | - | - | 1件: 113 113 💬
|
454 | Vamorolone | 1件: Vamorolone Vamorolone | 1件: Vamorolone
Vamorolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 113 113 💬
|
455 | Vamorolone 0.25 MG/DAY/DAY | 1件: Vamorolone Vamorolone | 1件: Vamorolone
Vamorolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 113 113 💬
|
456 | Vamorolone 0.25 MG/KG/DAY | 1件: Vamorolone Vamorolone | 1件: Vamorolone
Vamorolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 113 113 💬
|
457 | Vamorolone 0.75 MG/DAY/DAY | 1件: Vamorolone Vamorolone | 1件: Vamorolone
Vamorolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 113 113 💬
|
458 | Vamorolone 0.75 MG/KG/DAY | 1件: Vamorolone Vamorolone | 1件: Vamorolone
Vamorolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 113 113 💬
|
459 | Vamorolone 2.0 MG/DAY/DAY | 1件: Vamorolone Vamorolone | 1件: Vamorolone
Vamorolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 113 113 💬
|
460 | Vamorolone 2.0 MG/KG/DAY | 1件: Vamorolone Vamorolone | 1件: Vamorolone
Vamorolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 113 113 💬
|
461 | Vamorolone 40 MG/ML oral suspension | 1件: Vamorolone Vamorolone | 1件: Vamorolone
Vamorolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 113 113 💬
|
462 | Vamorolone 6.0 MG/DAY/DAY | 1件: Vamorolone Vamorolone | 1件: Vamorolone
Vamorolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 113 113 💬
|
463 | Vamorolone 6.0 MG/KG/DAY | 1件: Vamorolone Vamorolone | 1件: Vamorolone
Vamorolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 113 113 💬
|
464 | VBP15 | - | - | - | - | 1件: 113 113 💬
|
465 | Ventilatory/ respiratory and other support assessment | - | - | - | - | 1件: 113 113 💬
|
466 | Vesleteplirsen | 1件: Vesleteplirsen Vesleteplirsen | - | - | - | 1件: 113 113 💬
|
467 | Viltepso | 1件: Viltolarsen Viltolarsen | 1件: Viltolarsen
Viltolarsen
💬
| 1件: DMD DMD 💬
| 5件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬 | 1件: 113 113 💬
|
468 | Viltolarsen | 1件: Viltolarsen Viltolarsen | 1件: Viltolarsen
Viltolarsen
💬
| 1件: DMD DMD 💬
| 5件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬 | 1件: 113 113 💬
|
469 | VIT C VIT E ZN SE | - | - | - | - | 1件: 113 113 💬
|
470 | VX-670 | - | - | - | - | 1件: 113 113 💬
|
471 | Vyondys 53 | 1件: Golodirsen Golodirsen | 1件: Golodirsen
Golodirsen
💬
| 1件: DMD DMD 💬
| 5件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬 | 1件: 113 113 💬
|
472 | Withings blood pressure monitor | - | - | - | - | 1件: 113 113 💬
|
473 | Withings body+ scale | - | - | - | - | 1件: 113 113 💬
|
474 | Withings steel HR | - | - | - | - | 1件: 113 113 💬
|
475 | WVE-210201 | - | - | - | - | 1件: 113 113 💬
|
476 | WVE-N531 | 1件: WVE-N531 WVE-N531 | - | - | - | 1件: 113 113 💬
|
477 | Xeomin | 1件: Botulinum toxin type A Botulinum toxin type A | 2件: Botulinum toxin type A
Botulinum toxin type A
,
Prabotulinumtoxin A
💬
| 1件: SNAP25 SNAP25 💬
| 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 7件: 5 5, 6, 7, 13, 15, 17, 113 💬
|